KEAP1 and cancer: The “hinge and latch” model postulates that, as both cancer-related mutations and non-canonical activators, such as p62, function to inhibit the two-site binding, inducers may function in the same way, and it has been proposed that in the presence of inducers, the low affinity DLG motif is released by Keap1.